ArticleBMC bioinformatics2021

A machine learning-based gene signature of response to the novel alkylating agent LP-184 distinguishes its potential tumor indications.

Umesh Kathad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.